Tudor Investment Corp
BLCM

Tudor Investment Corp’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Tudor Investment Corp’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,115
Closed -$73K – 1281
2018
Q1 		$73K Buy
+1,115
New +$84.2K ﹤0.01% 936
2017
Q3 		– Sell
-1,302
Closed -$152K – 1299
2017
Q2 		$152K Sell
1,302
-5,504
-81% -$683K ﹤0.01% 925
2017
Q1 		$840K Buy
+6,806
New +$892K 0.03% 458
2015
Q1 		– Sell
-1,000
Closed -$230K – 1662
2014
Q4 		$230K Buy
+1,000
New +$214K 0.01% 1204

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's BLCM Position: Q2 2018 in Review

Tudor Investment Corp sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2018, closing a stake of 1,115 shares — an estimated $73K sold.

Tudor Investment Corp first reported a position in BLCM in Q4 2014 and held it in 4 quarters. The position peaked at $840K in Q1 2017. 96 funds tracked by Wall St. Rank hold BLCM as of Q2 2018.

  • Tudor Investment Corp reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Tudor Investment Corp sold 1,115 Bellicum Pharmaceuticals, Inc. shares in Q2 2018, an estimated $73K.
  • Tudor Investment Corp first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • Tudor Investment Corp's Bellicum Pharmaceuticals, Inc. position peaked at $840K in Q1 2017.
  • 96 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2018.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.